Market revenue in 2022 | USD 129.4 million |
Market revenue in 2030 | USD 262.3 million |
Growth rate | 9.2% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.85% in 2022. Horizon Databook has segmented the Italy non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Italy is one of the most lucrative markets in Europe. High adoption of NIPT, supportive guidelines for the usage of NIPT, and increasing awareness among the target population are anticipated to fuel market growth. The proportion of women using NIPT in Italy is higher than the average proportion in Europe.
Moreover, there are official guidelines to support the use of NIPT for high-risk women. In 2019, NIPT was launched in Tuscany as a public healthcare tool in the birth path. The use of NIPT for high-risk women in Italy is supported by official guidelines, however, only two areas presently reimburse for the test.
The country has a high adoption of NIPT via private clinics. Favorable government initiatives and development of independent noninvasive prenatal testing centers are expected to further boost market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Italy non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account